These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 29843242)

  • 1. A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.
    Alosco ML; Sugarman MA; Besser LM; Tripodis Y; Martin B; Palmisano JN; Kowall NW; Au R; Mez J; DeCarli C; Stein TD; McKee AC; Killiany RJ; Stern RA
    J Alzheimers Dis; 2018; 63(4):1347-1360. PubMed ID: 29843242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.
    Alosco ML; Duskin J; Besser LM; Martin B; Chaisson CE; Gunstad J; Kowall NW; McKee AC; Stern RA; Tripodis Y
    J Alzheimers Dis; 2017; 57(3):953-968. PubMed ID: 28304301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer's disease.
    Nagaraja N; DeKosky S; Duara R; Kong L; Wang WE; Vaillancourt D; Albayram M
    Neuroimage Clin; 2023; 38():103437. PubMed ID: 37245492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
    Pradeep A; Raghavan S; Przybelski SA; Preboske GM; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
    Alzheimers Res Ther; 2024 Jul; 16(1):157. PubMed ID: 38987827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Antemortem FLAIR White Matter Hyperintensities and Neuropathology in Brain Donors Exposed to Repetitive Head Impacts.
    Uretsky M; Bouix S; Killiany RJ; Tripodis Y; Martin B; Palmisano J; Mian AZ; Buch K; Farris C; Daneshvar DH; Dwyer B; Goldstein L; Katz D; Nowinski C; Cantu R; Kowall N; Huber BR; Stern RA; Alvarez VE; Stein TD; McKee A; Mez J; Alosco ML
    Neurology; 2022 Jan; 98(1):e27-e39. PubMed ID: 34819338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.
    Sible IJ; Bangen KJ; Blanken AE; Ho JK; Nation DA
    J Alzheimers Dis; 2021; 83(1):65-75. PubMed ID: 34250941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer's disease that emerge prior to dementia.
    Schoemaker D; Zanon Zotin MC; Chen K; Igwe KC; Vila-Castelar C; Martinez J; Baena A; Fox-Fuller JT; Lopera F; Reiman EM; Brickman AM; Quiroz YT
    Alzheimers Res Ther; 2022 Jun; 14(1):89. PubMed ID: 35768838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
    J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.
    Dallaire-Théroux C; Callahan BL; Potvin O; Saikali S; Duchesne S
    J Alzheimers Dis; 2017; 57(2):575-601. PubMed ID: 28282807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.
    Lee S; Zimmerman ME; Narkhede A; Nasrabady SE; Tosto G; Meier IB; Benzinger TLS; Marcus DS; Fagan AM; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Fӧrster S; Schofield PR; Sperling RA; Johnson KA; Chhatwal JP; Salloway S; Correia S; Jack CR; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    PLoS One; 2018; 13(5):e0195838. PubMed ID: 29742105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia.
    Nichols E; Merrick R; Hay SI; Himali D; Himali JJ; Hunter S; Keage HAD; Latimer CS; Scott MR; Steinmetz JD; Walker JM; Wharton SB; Wiedner CD; Crane PK; Keene CD; Launer LJ; Matthews FE; Schneider J; Seshadri S; White L; Brayne C; Vos T
    Lancet Healthy Longev; 2023 Mar; 4(3):e115-e125. PubMed ID: 36870337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
    Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
    Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
    Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
    Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
    Karanth SD; Katsumata Y; Nelson PT; Fardo DW; McDowell JK; Schmitt FA; Kryscio RJ; Browning SR; Braithwaite D; Arnold SM; Abner EL
    Brain; 2022 Jul; 145(7):2518-2527. PubMed ID: 35094057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer's neuropathology.
    Teylan M; Besser LM; Crary JF; Mock C; Gauthreaux K; Thomas NM; Chen YC; Kukull WA
    Lab Invest; 2019 Jul; 99(7):1049-1055. PubMed ID: 30710118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy.
    Xu C; Apostolova LG; Oblak AL; Gao S
    J Alzheimers Dis; 2020; 73(4):1305-1311. PubMed ID: 31929164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.